1. Zaba B, Boerma T, White R. Monitoring the AIDS epidemic using HIV prevalence data among young women attending antenatal clinics: prospects and problems. AIDS 2000; 14: 1633–1645.
2. WHO. Evaluation of a national AIDS programme. A methods package.1. Prevention of HIV infection. WHO/GPA/TCO/SEF/94.1. 1994. WHO: Geneva.
3. UNAIDS/WHO/MEASURE Evaluation/USAID. National AIDS programmes: a guide for monitoring and evaluation. Draft, 1999. Geneva: UNAIDS/WHO.
4. Mahomed K, et al. Seroprevalence of HIV infection amongst antenatal women in greater Harare, Zimbabwe. Central African Journal of Medicine 1991; 37: 322–325.
5. Mbizvo MT, et al. Trends in HIV-1 and HIV-2 prevalence and risk factors in pregnant women in Harare, Zimbabwe. Central African Journal of Medicine 1996; 42: 14–21.
6. Mahomva AI, et al. HIV prevalence and trends from data in Zimbabwe, 1997–2004. Sexually Transmitted Infection 2006; 82 (Suppl. I): i42–i47.
7. Malaba LC, et al. Effect of postpartum maternal or neonatal vitamin A supplementation on infant mortality among infants born to HIV-negative mothers in Zimbabwe. American Journal of Clinical Nutrition 2005; 81: 454–60.
8. Humphrey JH, et al. Effects of a single large dose of vitamin A, given during the postpartum period to HIV-positive women and their infants, on child HIV infection, HIV-free survival, and mortality. Journal of Infectious Diseases 2006; 193: 860–871.
9. Humphrey JH, et al. HIV incidence among postpartum women in Zimbabwe: risk factors and the effect of vitamin A supplementation. AIDS 2006; 20: 1437–1446.
10. Iliff PJ, et al. Early exclusive breastfeeding reduces the risk of postnatal HIV-1 transmission and increases HIV-free survival. AIDS 2005; 19: 699–708.
11. Reeves JD, Doms RW. Human immunodeficiency virus type 2. Journal of General Virology 2002; 83: 1253–1265.
12. Rodes B, et al. Viral response to antiretroviral therapy in a patient co infected with HIV Type 1 and Type 2. Clinical Infectious Diseases 2005; 41: e19–e21.
13. Graham WJ, Newell M.-L. Seizing the opportunity: collaborative initiatives to reduce HIV and maternal mortality. Lancet 1999; 353: 836–839.
14. Temmerman M, et al. Infection with HIV as a risk factor for adverse obstetrical outcome. AIDS 1990; 4: 1087–1093.
15. Ministry of Health and Child Welfare. National survey of HIV and syphilis prevalence among women attending antenatal clinics in Zimbabwe, 2002, pp. 1–38, 2002.
16. Gregson S, et al. Study of bias in HIV-1 surveillance data in a high contraceptive prevalence population in sub-Saharan Africa. AIDS 2002; 16: 643–652.
17. Ministry of Health and Child Welfare. Zimbabwe National HIV and AIDS Estimates. Zimbabwe: MOHCW, 2003.
18. UNAIDS. Evidence for HIV decline in Zimbabwe: a comprehensive review of the epidemiological data, pp. 1–45, 2006.
19. Gregson S, et al. HIV decline associated with behaviour change in Eastern Zimbabwe. Science 2006; 311: 664–666.
20. Sarr AD, et al. HIV-1 and HIV-2 dual infection: lack of HIV-2 provirus correlates with low CD4+ lymphocyte counts. AIDS 1998; 12: 131–137.
21. Duncan ME, et al. First coitus before menarche and risk of sexually transmitted disease. Lancet 1990; 335: 338–340.
22. Pettifor AE, et al. Early age of first sex: a risk factor for HIV infection among women in Zimbabwe. AIDS 2004; 18: 1435–1442.
23. Casella JF. Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active anti-retroviral therapy. A collaborative analysis. Lancet 2005; 335: 1131–1137.
24. Gregson S, Zaba B, Garnett GP. Low fertility in women with HIV and the impact of the epidemic on orphanhood and early childhood mortality in sub-saharan Africa. AIDS 1999; 13: S249–S257.
25. Gray RH, et al. Population-based study of fertility in women with HIV-1 infection in Uganda. Lancet 1998; 351: 98–103.
26. Terceira N, et al. The contribution of HIV to fertility decline in rural Zimbabwe, 1980–2000. Population Studies 2003; 57: 149–164.